Hematopoietic stem cells are identified based on their functional ability to migrate via the blood circulation of transplanted recipients, to home to the host bone marrow and to durably repopulate this organ with high levels of maturing myeloid and lymphoid cells. While a small pool of undifferentiated stem cells with the potential to repeat the entire process in serially transplanted recipients is maintained within the bone marrow, maturing cells are continuously released into the circulation. In recent years pre-clinical, functional in vivo models for human stem cells have been developed, using immune-deficient mice or pre-immune, fetal sheep as recipients. The mechanism of human stem cell migration, homing and repopulation in transplanted immune-deficient NOD/SCID and NOD/SCID/B2m null mice as well as the accessory mediators that facilitate these processes, will be reviewed. In particular, the essential roles of the chemokine SDF-1 and its receptor CXCR4 which mediate and regulate stem cell homing and repopulation will be discussed.
Introduction
During embryonic development, blood-forming stem cells are first isolated from the yolk sac and AGM region and later from the fetal liver. Fetal liver stem cells migrate via the blood circulation, home to the fetal bone marrow and repopulate this tissue with high levels of maturing blood cells of all lineages, which in turn are released into the circulation while maintaining a small pool of undifferentiated stem cells within the bone marrow. However, murine stem cells isolated from the yolk sac and AGM region before circulation is established are mostly not definitive stem cells, ie will not home and repopulate transplanted mice pre-conditioned with a lethal dose of total body irradiation, since they require an additional in vitro culture period with stromal cells and cytokines before they are fully developed from their pre-definitive state and become definitive, repopulating stem cells. These stem cells, however, can give rise to hematopoietic progeny if they are co-cultured with supportive non-hematopoietic fetal liver cells 1 or directly injected into the liver of fetuses pre-conditioned with lowdose chemotherapy. 2 Thus, fetal liver stem cells are definitive, repopulating stem cells capable of rescuing lethally irradiated murine recipients without the need for any in vitro incubation periods, are fetal liver stem cells. [3] [4] [5] [6] [7] After birth the majority of blood-forming stem cells are retained in the bone marrow, however, very low levels of stem cells are also present in the blood circulation. These low levels can be dramatically increased by repetitive daily injections of cytokines such as G-CSF as well as by administration of cytotoxic DNA damag- ing drugs such as cyclophosphamide, which are also used for chemotherapy of patients. This increase in stem and progenitor cells in the circulation is termed mobilization and is clinically used to harvest stem cells both for autologous and for allogeneic transplantation. 8, 9 The essential roles of SDF-1 and CXCR4 in murine embryonic development and adult hematopoiesis
The CXC chemokine stromal cell-derived factor 1 (SDF-1, also named CXCL-12) is produced by multiple bone marrow (BM) stromal cell types, and by epithelial cells in many organs. 10, 11 BM SDF-1 is mostly produced by immature osteoblasts in the endosteum region adjacent to stem cell niches, 12 is highly expressed by human and murine BM endothelium [12] [13] [14] and is also produced by mesenchymal adipocyte cell lines such as MS-5 and 14F1.1 which are known to support both human and murine stem cells in vitro. [15] [16] [17] [18] SDF-1 is implicated in migration, proliferation, differentiation and survival of many cell types including human and murine hematopoietic stem and progenitor cells. 19, 20 CXCR4 (also termed CD184), the seven transmembrane G-protein coupled receptor of SDF-1, is widely expressed by a variety of cell types including hematopoietic, endothelial, stromal and neuronal cells. 21 Studies with knockout models revealed that murine embryos which lack SDF-1 or CXCR4, have multiple defects, which are lethal, including impaired bone marrow lymphoid and myeloid hematopoiesis. However, while B lymphopoiesis in the fetal liver was also impaired due to the fact that this chemokine is also a pre-B cell growth factor, T cell development in the embryonic thymus and myeloid development in the fetal liver were not affected. [22] [23] [24] [25] These results demonstrate an essential role for SDF-1 and its receptor in definitive fetal liver stem cell homing to the bone marrow and/or hematopoietic retention and repopulation of this organ during embryonic development. Unexpectedly, fetal liver cells isolated from CXCR4
null embryos can engraft the marrow of transplanted adult wild-type mice, pre-conditioned with irradiation. However, stem cell self-renewal, retention of maturing hematopoietic cells within the bone marrow and migration patterns of both myeloid and lymphoid progenitor cells, which include thymic T cell development were defective. 26, 27 Moreover, while the levels of donor CXCR4 null cells in the host bone marrow 1 month post transplantation were reduced, 26, 27 the levels of immature CXCR4 null cells with primitive stem and progenitor cell phenotype (Sca-1 + /ckit
) 9 weeks post transplantation with a high cell dose, were normal. 26 . However, transplantation of CXCR4 null cells recovered from the bone marrow of primary transplanted recipients with normal levels of immature CXCR4 null cells into serially transplanted secondary recipients, resulted in signifi-cantly reduced levels of donor-derived reconstitution. 26 These results demonstrate an essential role for SDF-1 and CXCR4 interactions also in definitive, long-term stem cell repopulation and development in transplanted, adult mice. Thus, CXCR4 null progenitor cells recovered from the murine fetal liver do not qualify as definitive, repopulating stem cells, since in addition to their inability to home and repopulate the bone marrow of the developing embryo, these cells also fail to durably give rise to high levels of multi-lineage myeloid and lymphoid cells in both primary and serially transplanted secondary murine recipients. These results are of significance since transplantation of stem cells from the bone marrow of p21 knockout mice 28 required five serial transplantations in order to fully reveal defects in stem cell self-renewal and repopulation potential, while CXCR4 null serial transplantations revealed significant defects in engraftment potential already in the primary recipients which were further intensified in secondary transplanted recipients! In addition, while CXCR4 null cells do not migrate to a gradient of SDF-1 in vitro in transwells, 24 preliminary results from our experiments demonstrate SDF-1 mediated adhesion and migration in three-dimensional extra cellular matrix (ECM)-like gels of CXCR4 null cells, suggesting that these cells can partially compensate for the absence of CXCR4. 29 Interestingly, platelets express CXCR4 and respond to SDF-1-mediated adhesion, including adhesion to bone marrow endothelium-bound SDF-1. Furthermore, these platelet microparticles also bind to murine stem cells and to immature human CD34 + cells via P-selectin and Mac-1 integrin antigens, and can increase murine stem cell homing and repopulation. 30, 31 These results suggest that CXCR4 + platelet microparticles in the circulation of adult wild-type mice transplanted with CXCR4 null fetal liver cells could also increase adhesion to the BM endothelium, homing and engraftment of CXCR4 null progenitor cells in response to SDF-1 signaling.
Human and murine SDF-1 are cross-reactive and differ in one amino acid, 32 enabling human CXCR4 to respond to murine SDF-1 signaling and vice versa. Murine T cells which over-express human CXCR4 and CD4 are mostly localized within the bone marrow of transgenic mice, 33 demonstrating a central role for this chemokine in retention of hematopoietic cells within the bone marrow microenvironment, most probably by induction of the major adhesion molecules and by regulating their cell cycle status. Mice reconstituted with progenitor cells infected with SDF-1 intrakine, which prevents surface CXCR4 expression, suffered from impaired myeloid and lymphoid (both B and T cell) hematopoiesis. 34 . Finally, transplantation of infected murine progenitor cells that over express SDF-1, resulted in increased myeloid and B lymphoid hematopoiesis (T cell development was impaired) 34 most probably due to the anti-apoptotic survival properties of this chemokine. 35 Taken together, these results demonstrate essential roles for SDF-1 and CXCR4 interactions both in embryonic development and in adult hematopoiesis in transplanted mice. In addition, these results suggest that SDF-1 is a key regulator of murine stem cell migration and homing. This chemokine also controls anchorage of repopulating stem cells in the bone marrow and the release of maturing cells into the blood circulation. In a recent publication Wright et al 36 elegantly demonstrate that purified adult murine stem cells express CXCR4, migrate towards a gradient of SDF-1 in vitro as the sole chemokine which can mediate migration of these cells of all the known chemokines. These results suggest an essential role for SDF-1/CXCR4 interactions also in adult murine stem celltrafficking and development.
Leukemia
Functional in vivo models for human stem cells: high-level multilineage human myeloid and lymphoid hematopoiesis in the bone marrow of cytokine stimulated SCID mice transplanted with human bone marrow cells
In the late 1980s and early 1990s in vivo models for human T cells 37 and hematopoietic progenitor cells were established. These models included implantation of fetal and adult hematopoietic organs 38, 39 and i.v. transplantation of human bone marrow mononuclear cells (MNC), using immune-deficient BNX 40 and SCID mice 41 as recipients and later also by i.p. injection into pre-immune sheep fetuses. 42 Immune-deficient mice were also used as recipients for malignant human cells isolated from leukemic patients. 43 The first report which demonstrated high levels of multilineage, immature and maturing lymphoid and myeloid engraftment (CD19 + pre-B cells, myeloid, erythroid, primitive blast and CFU-GEMM multilineage colony-forming cells) utilized SCID recipient mice. This model required pre-conditioning of the mice with a sublethal dose (400 cGy) of total body irradiation, i.v. transplantation of recipients with ෂ40 million human bone marrow MNC and stimulation with human cytokines (SCF, IL-3 and GM-CSF) by alternate day i.p. injections for 1 month. 44 In highly engrafted mice the levels of human hematopoiesis in the murine bone marrow was Ͼ50% and the addition of human erythropoietin to the cytokine cocktail led to the development of human red blood cells in vivo. This report was followed by another report which demonstrated high-level multilineage immature and maturing myeloid and lymphoid human repopulation of the murine bone marrow which did not require cytokine stimulation using ෂ20 million human cord blood MNC as the source of hematopoietic stem cells in transplanted SCID mice. 45 These results demonstrate that the murine genome (which shows ෂ85% identity of 1196 orthologous sequences to the human genome 46 ) can support human stem cell migration in the murine circulation and high-level multilineage repopulation in the bone marrow of transplanted SCID mice, even though some of the cytokines, such as IL-3 and GM-CSF, are not cross-reactive and murine steel factor is significantly less potent for human hematopoiesis than the human cytokine. 44 However, these mice did not support engraftment when enriched immature human bone marrow or cord blood CD34 + cells were transplanted alone. Even with human cytokine stimulation, engraftment levels in serially transplanted secondary SCID recipients transplanted with cells recovered from primary transplanted mice were very low, most probably due to natural killer cells, myeloid cells and complement-mediated residual immunity of SCID mice (data not shown). These results also demonstrate a crucial role for differentiated hematopoietic MNC in human stem cell repopulation of SCID mice, which served as accessory cells. Therefore, in order to further identify the cell surface phenotype of human stem cells capable of SCID mice repopulation, sorting experiments were done with leukemic cells. 47 Enriched leukemic progenitor cells from newly diagnosed AML patients, can engraft the bone marrow of immune-deficient SCID mice in response to human cytokine stimulation, and can initiate many features of the original disease also in transplanted mice. The cell surface phenotype of leukemic stem cells from one AML patient with the FAB subtype M1, were documented to have the more primitive, undifferentiated CD34
− cell surface phenotype. These leukemic stem cells were termed: SCID leukemia initiating cells (SLIC). In a follow-up report using NOD/SCID mice as recipients, this phenotype was found to be dominant in human AML, including other FAB subtypes and SLIC were shown to have the potential to home and to initiate the disease also in serially transplanted secondary murine recipients. 48 Interestingly, in one report CD34-negative MNC isolated from a patient with AML (M5) also engrafted SCID mice and some of the leukemic cells recovered from the murine BM were CD34 + , demonstrating that there are also primitive CD34
− SLIC and that these cells can acquire CD34 expression in vivo.
49

Identification of human SCID repopulating cells (SRC) in transplanted NOD/SCID mice
Non-obese diabetes (NOD) mice are an outbred strain with multiple immunological defects which lead to T cell-mediated autoimmune diabetes. These mice also have defects in their myeloid cells, complement pathway and unsensitized NOD mice have reduced NK cell activity. Therefore, Shultz et al 50 have crossed the SCID mutation over the NOD background, creating NOD/LtSz-Prkdc scid (hereafter termed NOD/SCID) mice with significantly reduced residual immunity compared to SCID mice. As expected, transplantation of human cells into NOD/SCID mice enables reduced human cell doses to engraft (about one log decrease), compared to SCID mice. 50 The frequency of SCID repopulating cells (SRC) in CB MNC, utilizing NOD/SCID mice, was determined as 1 in 9.3 × 10 5 cells. 51 Most importantly, due to their reduced residual immunity and also better supporting bone marrow microenvironment for immature human progenitor cells (John Dick, personal communication), these mice also support migration, homing and repopulation of purified human hematopoietic subsets which include immature CD34 + cells, more primitive, undifferentiated CD34
+
/CD38
− cells and to a lesser degree, undifferentiated CD34 negative cells also. 
/Thy1
+ cells were detected in the murine bone marrow 2 days post transplantation. Over the next 4-8 weeks, their levels increased almost being restored to the numbers originally injected, suggesting that more primitive cells had engrafted. 54 In contrast to previous work with human bone marrow cells transplanted into SCID mice, there were no major differences in the levels of engraftment when human cytokine stimulation was added, suggesting that in addition to immunological differences between SCID and NOD/SCID mice there are also differences in the ability of the murine marrow stromal cells to support human cells. While cytokine stimulation did not effect the total levels of human cells there were higher levels of immature human cells which were retained for longer duration in cytokine-treated mice. 55, 56 Furthermore, cell sorting experiments revealed that only primitive, undifferentiated CD34
− cells engraft transplanted NOD/SCID mice while CD34
+ cells (with high CD38 expression), which contain both short-term CFC and long-term LTC-IC colony-forming progenitor cells, do not. 52 Therefore, primitive CD34
− cells which were capable of multilineage (lymphoid and myeloid) repopulation in the bone marrow of transplanted NOD/SCID mice, were termed SCID-repopulating cells (SRC). 52 Interestingly, Conneally et al 57 reported that sorted human CD34 + /CD38 + cord blood cells also contain primitive cells, which produce both CD34
+ B cells and CD34 + myeloid progenitors in the bone marrow of transplanted NOD/SCID mice. These mice were pre-conditioned with sublethal (350 cGy) total body irradiation and co-transplanted with one million irradiated (1500 cGy) human bone marrow cells together with the sorted CD34
+ cells. These primitive human lymphoid and myeloid producing cells in the bone marrow of transplanted NOD/SCID mice were termed competitive repopulating unit (CRU). 57 While the majority of CRU are primitive CD34 
/CD38
− stem cells to maintain their undifferentiated state in addition to their multilineage repopulation/ differentiation capacity. Clonal stem cell analysis of human SRCs combined with serial transplantations into secondary NOD/SCID mice recipients, revealed the existence of both short-and long-term repopulating cells, demonstrating variable self-renewal capacities within the stem cell compartment. 62 Recently, we have reported that the cell surface phenotype of human SRC is CD34
−/low (these cells are 
/CXCR4
+ cells sorted with neutralizing CXCR4 antibodies, have similar NOD/SCID mice repopulating capacity, ruling out the need for functional CXCR4 and the crucial role of SDF-1 signaling in human SRC function. 65 These experiments required a very high cell dose (up to 60-fold increase) in order to achieve similar levels of repopulation obtained in a previous report where the entire primitive undifferentiated CB CD34
− population was transplanted. 66 To elucidate the role of SDF-1/CXCR4 interactions in the homing and repopulation of human CB CD34
− sorted cells, the repopulation potential of these cells was compared to control CD34 + cells with unmanipulated CXCR4, or CD34 + cells which migrated to a gradient of SDF-1 prior to transplantation. We found that CD34 + /CXCR4 − sorted cells store intracellular CXCR4, which is rapidly induced to membrane expression within a few hours, supporting low homing and repopulation. Short-term cytokine stimulation for 48 h restored high levels of SDF-1-dependent SRC repopulation, similar to total CD34 + cell transplantation. 67 Moreover, we demonstrated up and downregulation of cell surface CXCR4 expression and function of the newly expressed receptors, on both CD34 + /CXCR4
+ and CD34 + /CXCR4 − cell subsets, and have shown that their homing to the murine BM and NOD/SCID repopulation is fully dependent on SDF-1/CXCR4 interactions. These results demonstrate that surface CXCR4 expression is a dynamic process, regulated by cytokines, chemokines, stromal cells, adhesion molecules and other environmental mediators which control SRC homing and repopulation potential.
NOD/SCID/B2m
null mice, an improved model for human hematopoiesis which better resembles autologous transplantation Due to their genetic background, NOD/SCID mice lack mature T and B lymphocyte activity, but still acquire NK cell activity. This innate immunity of the host, could be reduced by injecting anti-NK cell antibodies prior to transplantation resulting in enhanced human cell engraftment. 58, 59, 68, 69 Knocking out the ␤2 microglobulin, which is required for the expression of MHC class I molecules, and crossing this mutation on the background of NOD/SCID mice, generated NOD/SCID/B2m null mice, which support higher levels of human cell engraftment due to the loss of NK cell activity. 70 The reduced immunity of these mice facilitate increased freLeukemia quencies of transplanted SRC by up to 11-fold, higher levels of multilineage repopulation in serially transplanted mice and significantly faster homing of primitive human cord blood CD34
−/low /CXCR4 + stem and progenitor cells into the murine bone marrow and spleen. 63, 64, 71 Enriched human cord blood CD34
+ cells homed to the BM and spleen of sublethally irradiated NOD/SCID/B2m null mice in a CXCR4-dependent manner (Figure 1) , as previously shown with NOD/SCID recipients. The stem cell compartment contains both shortand long-term repopulation activities with variable selfrenewal potential. 62 
Figure 1
Human CB CD34 + cells were isolated as described 64 and were incubated with or without neutralizing anti-human CXCR4 mAb (10 g/10 cells also engrafted NOD/SCID mice but in a reduced fashion. 72 Since short-term repopulating cells demonstrate higher sensitivity to host NK cell activity, 72 inhibition of NK cell activity in NOD/SCID mice enhanced T cell development in the murine thymus which also could be obtained by genetically knockout models. 73 A similar approach of inactivating murine NK cell activity was taken by generating NOD/SCID/common-gamma-chain knockout mice. These mice acquire immune deficiency of NOD/SCID with no NK cell activity, enabling higher levels of human cells in the murine circulation compared with NOD/SCID/B2m null mice. 74 These results demonstrate that despite the faster homing kinetics and lower human cell dose required for transplantation, the same human cell populations initiate short-and long-term repopulation in both NOD/SCID and NOD/SCID/B2m null recipient mice in response to SDF-1. However, NOD/SCID/B2m null mice better document shortterm repopulating cells due to their reduced innate immunity.
Cell cycle status of SRC
Hematopoietic stem cells are mostly non-cycling quiescent cells, having the potential of multiple divisions with selfrenewal capacity as well as giving rise to different committed maturing cells. Several studies have documented the cell cycle status of long-term repopulating stem cells. Adult human mobilized peripheral blood (MPB) CD34
+ enriched cycling G1 cells can home to the BM of conditioned NOD/SCID mice, 75 however, long-term repopulation capacity was associated predominantly within the quiescent, G0 phase of the cell cycle. 76 In vitro cytokine stimulation induces transition of a fraction of the human progenitor cells into the cycling G1 phase, but in contrast to G1 cells, only quiescent cells that remained within the G0 phase and were not induced to cycle, retained NOD/SCID repopulation capacity, although slightly decreased compared to freshly isolated G0 cells. 76 Looking at neonate CD34 + enriched cells we also found that non-stimulated CB CD34 + G0 cells (about 64% of all freshly isolated CD34 + cells) efficiently engrafted immune-deficient NOD/SCID and NOD/SCID/B2m null mice, whereas cycling G1 cells failed to durably repopulate the BM of sublethally irradiated recipients. Two-three day cytokine stimulation of CB CD34
+ cells induced the production of non-repopulating G1 CD34
+ cells with increased migration capacity to the chemokine SDF-1 and homing to the bone marrow of NOD/SCID mice, however, without gaining repopulation activity 1-month post transplantation. Interestingly, in cotransplantation experiments, the presence of cycling G1 cells increased the repopulation capacity of sorted, quiescent G0 cells, compared with injection of each fraction separately, demonstrating an accessory effect by the G1 cycling cells. 77 Glimm et al 78 reported that a longer culture period of 5 days exposure to cytokines led to the loss of repopulating potential by G0 CB CD34 + cells, while stem cell activity was found restricted to the G1-induced cells co-transplanted with irradiated accessory cells. Of note is the study published by Wilpshaar et al, 79 documenting similar NOD/SCID repopulation capacity by both freshly isolated CB CD34 + G0 and G1 fractions. These results suggest a different correlation between mitotic quiescence and function as compared with adult MPB CD34 + cells. A possible explanation for the high repopulation potential demonstrated by cycling G1 CB CD34 + cells in this study can be mainly contributed by co-transplanting the cycling G1 fraction with a high dose of accessory cells (10 7 nonadherent adult BM CD34 − irradiated cells/mouse) that are known to improve homing and engraftment. Different sorting settings also have to be considered, since significant accessory effect might be contributed by the presence of quiescent G0 cells in the cycling G1 fraction (documenting only 33% noncycling quiescent G0 cells in freshly isolated human CB CD34 + cells in this report 79 compared with 64-68% quiescent G0 cells in other studies). 77, 80, 81 Definitive repopulating murine stem cells are also mostly quiescent within the G0/G1 phase of the cell cycle. Injection of 100 Thy1.1 lo /Lin −/lo /Sca-1 + G0/G1 cells rescued 90% of lethally irradiated mice while only 25% of the recipients injected with cycling S/G2/M cells, survived.
82 G0/G1 repopulating Sca-1
+
Lin
− stem cells were also defined phenotypically based on adhesion molecule expression. 83 Further fractionation of Rh lo /Ho lo/sp /Lin − /Sca-1 + cells with PY, revealed a three-fold higher frequency of quiescent G0 in the in vivo repopulating stem cells compared with their G1 counterparts, 84 demonstrating similar high definitive repopulating stem cell activity by human and murine quiescent G0 cells. Murine BM cells cultured in vitro showed fluctuated engraftment capacity, according to the cell cycle phase, demonstrating that the cell cycle status is an important regulator of stem cell activity. 85 
Repopulation potential of pre-definitive CD34
− /CD38 − stem cells
The sialomucin CD34 is expressed by immature human hematopoietic cells such as clonogenic progenitors and SRC/stem cells and is widely used as a marker to isolate undifferentiated repopulating stem cells for clinical protocols. The first evidence for stem cell activity within a primitive cell population that lacks CD34 expression came from the murine system, 86 however, a reversible CD34 cell surface expression by murine stem cells was also demonstrated. 87 The repopulating potential was mostly acquired by naive non-stimulated CD34 − cells, while 5-FU treatment of the donor mice led to equal stem cell activity of both CD34 + and CD34 − cells. 87 
Undifferentiated, quiescent CD34
− cells were also identified within the BM side population (SP) of murine, Rhesus and human hematopoietic cells. 88 Bhatia et al demonstrated lack of repopulation in the majority of mice transplanted with human CB Lin − accessory cells and only low levels of engraftment in a small minority of transplanted NOD/SCID recipients. 53, 89 In another study, human CD34 − cells derived from either CB, BM or MPB could repopulate only 5/125 transplanted mice, demonstrating low repopulating potential of these quiescent cells. 90 In addition to the quiescent nature of CD34 − cells, low levels of cell surface CXCR4 expression associated with poor SDF-1 migration and moreover homing capacity below the detection level in NOD/SCID mice 64 
CD34
− cells engrafted primary recipients to similar levels as their BM counterparts, but human hematopoiesis was exhausted earlier in serially secondary and tertiary transplanted recipients, 92 demonstrating mostly short-term repopu- + as well as CD34 − cells in the recipient BM. Next, human BM cells recovered from primary recipients were further fractionated, based on CD34 expression, and transplanted into secondary recipients. Both fractions, regardless of CD34 expression by the initial progenitor subset, gave rise to long-term engraftment with multilineage differentiation in the secondary recipient, demonstrating dynamic, reversible expression of surface CD34 by adult human BM cells in vivo. 93 The concept of a pre-definitive human CB Lin
− stem cell, which requires additional in vitro stimulations in order to activate stem cell homing/repopulation potential prior to NOD/SCID transplantation, is supported by several studies. Cytokine stimulation or stromal co-cultures induced CD34
+ expression, in vitro colony formation and in vivo repopulation of transplanted NOD/SCID mice by enriched human CB Lin − /CD34 − cells. 94 Moreover, enriched CD34
+ cells improved the engraftment in NOD/SCID recipients of their counterpart CD34 − cells that gave rise to both CD34
+ as well as to CD34 − progeny cells, demonstrating both the repopulating stem cell potential of CD34 − cells and the crucial role of accessory CD34
+ cells, which are needed for definitive stem cell activity by this population. 89 Clinical investigations revealed distinct biological properties demonstrated by CD34
− cells that were recovered from the BM of patients transplanted either with enriched CD34
+ cells compared to total MNC in autologous transplantation. While the levels of CD34 − cells recovered from the bone marrow of patients transplanted with enriched CD34 + cells were normal, only CD34
− cells derived from MNC transplanted patients, could gain cytokine-mediated surface CD34 expression as well as colony-forming activity in vitro.
95
The accessory effect: non-repopulating mature cells facilitate the engraftment of definitive, repopulating stem cells SRC are undifferentiated quiescent cells with high multilineage repopulation potential. Theoretically, transplantation of a single pluripotent stem cell should be sufficient to initiate long-term host repopulation, however, this process is dose dependent and requires a minimal threshold of transplanted cells which are needed to facilitate stem cell homing and both short-term and long-term repopulation. This obstacle can be overcome by co-transplanting undifferentiated enriched stem cell subsets with irradiated or non-irradiated mature nonengrafting cells (such as Lin + or total mononuclear (MNC), CD34 − cells) from various sources, as described hereafter. Less than 500 human Lin − /CD34 + /CD38 − purified cells could engraft a minority of transplanted NOD/SCID mice when cotransplanted with accessory cells. 57, 66 In these two studies, normal irradiated BM cells or MNC CD34
− cells, either from CB or BM, were used as accessory cells. Similarly, a single murine male BM-derived stem cell that homed to the BM of a primary female recipient, could also repopulate a secondary recipient with hematopoietic and non-hematopoietic male donor-derived cells when co-transplanted with 2 × 10 4 female BM accessory cells, a population enriched for progenitors and short-term repopulating cells. 96 Stromal cells are also known to support hematopoietic stem cells. Human BM transgenic stromal cells secreting hIL-3 are essential for high levels of human hematopoiesis in transplanted immune-deficient bnx mice with enriched human BM CD34 + cells. Other single
Leukemia cytokines such as IL-2, IL-7 and FLT3-L failed to achieve the enhancing effect. 97 Non-repopulating human CB CD34 + /CD38 +/high cells that failed to home when transplanted into primary NOD/SCID mice recipients (8 × 10 5 cells/mouse) as a freshly purified fraction, 64 homed successfully to the bone marrow of NOD/SCID recipients when co-transplanted with mature cells present in the entire mononuclear fraction of CB cells (Figure 2) . Transient, short-term repopulation of NOD/SCID mice was obtained by co-transplanting the sorted CD34 + /CD38 +/high CB subset with Ͼ3 × 10 6 irradiated MNC CD34 -− cells. 59 The accessory effect is also observed within the heterogeneous CD34
+ fraction. Other reports documented long-term maintenance and expansion of undifferentiated CD34
− cells in vivo, only when co-transplanted with the more differentiated CD34
+ cells. 60, 61 The lack of the facilitating effect by accessory cells led to the differentiation of all transplanted CD34 + /CD38 − cells that acquired the more mature CD34
+ phenotype. Cytokine secretion by immature CD34 + cells is also suggested to mediate the accessory effect.
Media conditioned by CD34
+ cells inhibited apoptosis and slightly stimulated the proliferation of other freshly isolated CD34 + cells. 98 In addition, more differentiated human CD34
+ cells, which include CXCR4 + cells, also secrete low levels of SDF-1 in an autocrine manner, 99 ,100 which could explain their reduced migration potential towards a exogenous gradient of SDF-1 in vitro compared to primitive, undifferentiated CD34
− cells which express higher levels of CXCR4, and do not secrete SDF-1. 63, 101 These phenomena could also explain the reduced homing and transient repopulation of CD34
+ cells, since both homing and repopulation are dependent on BM SDF-1 signals.
Non-hematopoietic cells can also serve as accessory mediators in the process of homing and repopulation. Short adhesion of enriched human CB CD34 + cells to the murine mesenchymal-adipocyte cell line 14F1.1 enhanced engraftment in NOD/SCID mice. 18 Co-transplanting human mesenchymal progenitor cells with enriched CD34
+ cells enhanced their repopulation of NOD/SCID mice. 102, 103 Mesenchymal-osteoblast co-transplantation facilitated long-term engraftment by purified murine stem cells across allogeneic MHC barriers. 104 Osteoblasts secrete high levels of SDF-1, 12 which also activate adhesion molecules, act as a survival and anti-apoptotic factor and might thus facilitate the engraftment potential of repopulating stem cells. The mechanism in which accessory cells assist stem cell engraftment is currently unknown. Bonnet et al 105 suggest that human cytokines secreted by accessory cells are required to support the survival of human repopulating cells, since in vivo administration of human cytokines led to similar levels of human cell engraftment obtained by co-transplantation of accessory cells. High cell dose transplantation of purified CD34 + cells alone accomplished the same effect. Several groups postulate a mechanism triggered by cell-to-cell contact. Adams et al 106 found that co-cultures of immature CD34 SDF-1. Murine BM cells covered with these particles repopulated significantly faster lethally irradiated mice. 30 Similarly, the chemokine receptor CCR5, released from the surface of various cell types as microparticles, was transferred to CCR5 − cells. Moreover, the transfer of CCR5 occurred from PBMCs on to endothelial cells during transendothelial migration, 107 which is an essential process preceding homing from the blood circulation into the BM microenvironment. Thus, transfer of molecules between neighboring or transmigrating cells during the homing process, might also contribute to increased homing/repopulation levels.
Homing of human CD34
+ cells
The fetal pre-immune sheep model, and sublethally irradiated immune-deficient mice are both permissive recipients for human hematopoiesis, and were also used to study homing of human stem cells from the blood circulation into the BM. Enriched human CD34 + cells could not be detected 3 h, but were documented 24 h post transplantation in the BM, spleen and liver of recipient sheep fetuses.
108 CXCR4 + SRC home and accumulate rapidly, within a few hours, in the BM and spleen of transplanted NOD/SCID/B2m null mice and at a significantly slower rate in transplanted NOD/SCID mice, both in response to murine SDF-1. 64 Several key molecules mediating the specific homing of human stem and progenitor cells into hematopoietic sites were identified. The major integrins VLA-4, VLA-5 and LFA-1 and their vascular ligands VCAM-1 and ICAM-1 were found to be crucial in the homing of enriched human CD34 + cells. 
/CXCR4
+ cells homed successfully to the BM and spleen of recipient mice, the more mature CD34
+ cells failed to home and required additional cytokine stimulation to gain homing activity, 64 apparently due to autocrine stimulation by secreted SDF-1 which interferes with exogenous BM SDF-1 signaling required for homing and repopulation. 99, 101 Potentiation of CD34 + /CD38 + cell homing could also be provided by co-transplanting accessory cells (Ref. 59 and Figure 2) . Nevertheless, these cells demonstrated only short-term transient repopulation.
58,59
The roles of SDF-1 and CXCR4 interactions in human stem cell homing and repopulation of NOD/SCID and NOD/SCID/B2m null mice SDF-1 induces chemotaxis 20 as well as trans-endothelial migration 109 and integrin-mediated firm arrest of immature human CD34
+ progenitor cells under shear flow. 110 Murine SDF-1 differs only in one amino acid from the human protein 32 and is therefore cross-reactive and induces SDF-1 response by human CXCR4 expressing cells. We demonstrated the essential role of SDF-1/CXCR4 interactions in both homing and high-level multilineage repopulation of immunedeficient NOD/SCID and serially transplanted NOD/SCID/B2m null mice by enriched human CD34 + stem and progenitor cells derived from CB, BM and MPB from healthy donors. 12, 63, 64 In particular, preventing SDF-1/CXCR4 interactions by neutralizing Ab directed against CXCR4 or SDF-1, or desensitizing CXCR4 expression on CD34 + cells by in vitro pre-incubation with a high concentration of SDF-1, significantly reduced homing and SRC-mediated repopulation of immune-deficient recipients. 63, 64 Anti-human CXCR4 mAb inhibited the homing of CB CD34 + cells to the BM, spleen and the liver but not to the lungs. 64, 111 Conversely, promoting SDF-1/CXCR4 interactions improved homing and repopulation. This manipulation could be directed by treating both donor human cells and murine recipients prior to transplantation. Increasing SDF-1 levels within the recipient BM by either conditioning the recipient with DNA damaging agents 12 or by direct injection of SDF-1, 64 led to higher levels of homing and repopulation. Short-term 24-48 h of in vitro cytokine stimulation with SCF and IL-6 induced upregulation of surface CXCR4 expression by immature human CD34 + cells, increased in vitro migration towards SDF-1 and in vivo homing and repopulation, 63, 64 demonstrating dynamic increase in expression of functional CXCR4.
Based on these results, freshly isolated CD34 + cells possessing the capability to home to sublethally irradiated NOD/SCID and NOD/SCID/B2m null recipients and to give rise to high levels of multilineage repopulation in both primary and serially transplanted immune-deficient mice were further characterized as CD38 
/CXCR4
− sorted cells harbor intracellular CXCR4, which can be rapidly translocated to the cell surface and be functionally expressed to mediate SDF-1-dependent, low repopulation of NOD/SCID mice. Both purified CXCR4
+ and CXCR4 − CD34 + subsets demonstrated CXCR4-dependent homing and engraftment of murine recipients, revealing dynamic expression of CXCR4 and SDF-1-controlled stem cell activity. 67 Although SDF-1 signaling is not fully understood, it is also found to act either directly or indirectly as a survival factor for human and murine progenitor cells and low SDF-1 levels mediate increased cycling and anti-apoptotic activities. 112, 113 Two daily injections of a high SDF-1 dose (10 g), blocked the cell cycle of primitive human repopulating cells in engrafted NOD/SCID mice, and increased human engraftment levels in secondary transplanted immune-deficient mice. 114 In addition, 2 days of in vitro stimulation with a low dose of this chemokine (100 ng/ml), significantly increased engraftment of NOD/SCID mice by human CB Lin − CD34 + cultured cells. 115 SDF-1/CXCR4 signaling is also required for the survival, expansion, and subsequent differentiation of early human T cell progenitors. 116 These studies demonstrate that both primary and secondary human NOD/SCID repopulating stem cells as well as thymic differentiating human T cell precursors functionally express CXCR4.
Of special interest is the relevance of SDF-1/CXCR4 interactions and signaling for clinical, CD34
+ enriched, transplantation protocols. Voermans 117 Therefore, we suggest an increase of SDF-1 levels in the recipient BM and short-term in vitro stimulation of human progenitors with SCF and IL-6, which increase CXCR4 expression, prior to clinical stem cell transplantation in order to improve SDF-1-dependent stem cell homing and repopulation.
A recent publication by Wright et al 36 demonstrated that purified adult murine hematopoietic stem cells migrate to SDF-1 and not to any other known chemokine, illustrating a similar role for SDF-1/CXCR4 interactions in the murine system which is more physiologically relevant, as key regulators of stem cell homing.
Concluding remarks and future directions
Homing of human stem and progenitor cells from the blood circulation of transplanted recipients into the BM microenvironment is a complicated multi-step process. The ability of stem cells to migrate selectively and to repopulate the BM with multilineage differentiating cells involves an interplay Leukemia between adhesion molecules, chemokines, cytokines, and interactions with BM endothelial and stromal cells. In addition, maturing and mature cells as well as cytokine stimulation facilitate homing, proliferation and the repopulation potential of human SRC/stem cells. In the current review we described the history of immune-deficient xenotransplantation murine models, ie SCID, NOD/SCID and NOD/SCID/B2m null mice, which are mostly used to study the mechanisms that mediate and regulate human stem cell function: homing and repopulation by immature human CD34 + and CD34 − enriched cells. In addition, the key roles of the chemokine SDF-1 and its receptor CXCR4 in SRC/stem cell homing and high-level multilineage repopulation in both primary and serially transplanted immune deficient mice were extensively discussed. SRC were phenotypically characterized as CD38 −/low /CXCR4 + cells. While definitive, repopulating stem cell activity was mainly documented within the human CD34 + enriched population, undifferentiated CD34
− cells also demonstrate equal repopulating potential in pre-immune fetal sheep. These cells demonstrate low levels of repopulation in transplanted NOD/SCID mice which is due to their reduced SDF-1-mediated migration and homing as well as dependence on accessory cells. Of interest, the repopulation potential of these cells in clinically transplanted recipients is currently unknown. This issue is important and has therapeutic value since all transplanted patients have only low levels (about 90% reduction) of primitive long-term culture-initiating cells. 119 . Similarly, functional CXCR4 expression on the cell surface of enriched human CD34
+ cells was found to be crucial, although CD34
− sorted cells harbor reduced levels of intracellular CXCR4, which can be induced by shortterm cytokine stimulation in vitro to cell surface expression and increased intracellular levels. Membrane translocation of this receptor is suggested to serve as a relatively early event that provides CD34 +
/CXCR4
− cells with low repopulation potential and mediates their homing to the murine BM. This repopulation potential can be enhanced to normal levels by short-term stimulation with cytokines prior to transplantation. This approach could improve the outcome of clinical stem cell transplantation by using SDF-1 and CXCR4 as vehicles to navigate stem cells to the bone marrow. Both CD34 and CXCR4 surface expression is dynamically regulated by environmental mediators. In addition, while human CD34 expression is also associated with differentiation, CXCR4 demonstrate a cycling pattern of expression which has definitive repopulation significance. Thus, the phenotypic profile of human cells sorted on the basis of CD34 or CXCR4 expression, reflects a snap shot of a particular time frame, which is dynamic and can rapidly change with time. Therefore, human stem cells should be assayed functionally, since their repopulation activity is regulated by their environment and is not cell autonomous, depending on immature and mature hematopoietic and non-hematopoietic cells. Thus, there is a cross-talk between primitive undifferentiated CD34 +
/CD38
− cells and immature CD34 + /CD38 + cells and differentiated cells, which affects both the quantity and quality of definitive repopulating human stem cells.
Lastly, two recent reports relate either increased CXCR4 expression on immature CD34
+ cells used clinically, or increased SDF-1-induced CD34 + cell motility with faster recovery in both allogeneic and autologous transplantations. 117, 118 Current data obtained by us and others, suggest that increase of SDF-1 levels in the recipient BM short-term in vitro stimulation with SCF and IL-6 and/or co-transplantation of accessory cells, can significantly improve the out-come, ie BM homing and repopulation potential by definitive human stem cells in both allogeneic and autologous clinical protocols.
Note
Due to the complexity of human stem cell homing and repopulation of immune-deficient mice field, we could not discuss many interesting studies, and we apologize to those whose excellent work could not be cited due to space limitations.
